JSA advised TPG, in relation to the proposed merger of its investee company, Quality Care India Limited (QCIL), with Aster DM Healthcare Limited, at a combined valuation of over USD 5 billion.
The transaction also contemplates a preferential issuance by Aster, prior to the merger, for an acquisition of 5% shareholding in QCIL. The transactions are subject to applicable regulatory and corporate approvals.
The combined entity will have a network of 38 hospitals and 10,150+ beds spread across 27 cities making it one of the top 3 hospital chains in India.
The transaction team comprises Lead Partners Iqbal Khan and Ambarish, Partner Ashid Basheer, and Senior Associate Varun Natarajan.
The competition team comprised Partner and Chair, Competition Law Nisha Kaur Uberoi, Partner Pranav Satyam, Senior Associates Akrathi Shetty and Kamal Sharma, and Associate Tarun Katariya.
Source: JSA’s LinkedIn Page
